Who We Are

Dr Paul Elvin

Director of Preclinical Research

Paul is a specialist in cancer drug discovery, with 27 years’ experience at AstraZeneca, where he provided project and scientific leadership for collaborative cross-functional delivery of small molecule and therapeutic antibody projects across all stages of drug discovery. Paul specifically developed translational science and delivery plans for biomarker strategies for proof of mechanism studies and patient selection.

Ask me about: drug discovery, pre and non-clinical research

Dr Paul Elvin Image

Sign up for our newsletter